Aditya Generic(Drugs) Profile
Key Indicators
- Authorised Capital ₹ 5.80 M
- Paid Up Capital ₹ 4.89 M
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.25 Cr
- Revenue Growth 17.14%
- Profit Growth 31.16%
- Ebitda 14.76%
- Net Worth 15.16%
- Total Assets 20.61%
About Aditya Generic(Drugs)
Aditya Generic(Drugs) Private Limited (AGPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 November 2009 and has a history of 15 years and two months. Its registered office is in Sonitpur, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.80 M and a paid-up capital of Rs 4.89 M.
The company currently has active open charges totaling ₹3.25 Cr.
Amitabh Das and Sobha Das serve as directors at the Company.
Company Details
- Location
Sonitpur, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232AS2009PTC009430
- Company No.
009430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Aditya Generic(Drugs)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amitabh Das  | Director | 30-Nov-2009 | Current |
| Sobha Das | Director | 30-Nov-2009 | Current |
Financial Performance of Aditya Generic(Drugs).
Aditya Generic(Drugs) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.14% increase. The company also saw a substantial improvement in profitability, with a 31.16% increase in profit. The company's net worth Soared by an impressive increase of 15.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aditya Generic(Drugs)?
In 2023, Aditya Generic(Drugs) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aditya Propeller (Auto) Private LimitedAmitabh Das and Sobha Das are mutual person
- Bikram Aditya Automotive Private Limited
Amitabh Das and Sobha Das are mutual person
- Aditya Electronics Private Limited
Amitabh Das and Sobha Das are mutual person
- Bikram Aditya Distributors Private Limited
Amitabh Das and Sobha Das are mutual person
- Adityas Centre Point Hotel Private Limited
Amitabh Das and Sobha Das are mutual person
Charges (Loans)
₹32.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 3.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2010 | Axis Bank Limited | ₹3.25 Cr | Open |
How Many Employees Work at Aditya Generic(Drugs)?
Unlock and access historical data on people associated with Aditya Generic(Drugs), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aditya Generic(Drugs), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditya Generic(Drugs)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
